Fenfluramine Hydrochloride

5 trials 2 recruiting NNeurology/Psychiatry Orphan designation

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

2 Recruiting

2 Completed trials

3 Sponsors

11 Countries

Phase III

Phase II

Phase III: 4 Phase II: 1

Oversight events:

1 corrective measure across 1 trial

View oversight register →

Indications tested

Lennox-Gastaut syndrome 1 Rett syndrome 1

Sponsors using this IMP

UCB Biosciences Inc. 2 Zogenix International Limited 2 Universitaetsklinikum Schleswig-Holstein AöR 1

All trials

5 total

A study to learn if fenfluramine hydrochloride is safe and works in people with Rett syndrome Pending

2025-523157-34-00 Phase III 7 countries UCB Biosciences Inc.
A study to learn how safe fenfluramine is, how well it works, and how it moves through the bloodstream in infants with Dravet syndrome Recruiting

2022-502359-75-00 Phase III 4 countries UCB Biosciences Inc.
Open label extension study for monitoring long-term safety in patients with Myoclonic Astatic Epilepsy (Doose-Syndrome) receiving Fenflurami… Recruiting

2024-518520-77-00 Phase II 1 country Universitaetsklinikum Schleswig-Holstein AöR
A Study to Examine the Efficacy and Safety of ZX008 in Subjects with CDKL5 Deficiency Disorder Ended

2023-506269-78-00 Phase III 8 countries Zogenix International Limited
An extension study to learn about the long-term safety of fenfluramine hydrochloride for seizures in children and adults with rare seizure d… Ended

2024-515680-61-00 Phase III 4 countries Zogenix International Limited

Showing 1–5 of 5 trials

← All drugs A–Z